NEW YORK, July 3, 2012 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
Global DNA Probes-Based Diagnostics Industry
This report analyzes the worldwide markets for DNA Probes-based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, Molecular HLA (Human Leukocyte Antigen) Typing, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 63 companies including many key and niche players such as Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson & Company, Beckman Coulter, Inc., bioMerieux, Celera Group, Gen-Probe Incorporated, Genzyme Corporation, Luminex Molecular Diagnostics, QIAGEN, Roche Diagnostics, and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-3Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Infectious Diseases I-4Cancer I-4Genetic Predisposition I-4Identity/Forensics I-4Molecular HLA Testing I-4Other Diagnostic Applications I-4II. EXECUTIVE SUMMARY
1. MARKET DYNAMICS II-1
Industry Overview II-1
DNA Probes: Robust Growth Ahead II-1
Decoding the Genetic Puzzle II-1
Advantages of DNA-Probe Tests II-2
Here is the original post:
Global DNA Probes-Based Diagnostics Industry
Recommendation and review posted by G. Smith
